Osteopontin protects against hyperoxia-induced lung injury by inhibiting nitric oxide synthases

Chinese Medical Journal

Volumn 123, Issue 7, 2010, Pages 929-935

  Zhang, Xiang Feng ^a   Liu, Shuang ^a   Zhou, Yu Jie ^a   Zhu, Guang Fa ^a   Foda, Hussein D ^b  

^a CAPITAL MEDICAL UNIVERSITY   (China)

^b STONY BROOK UNIVERSITY   (United States)

Author keywords

Acute lung injury; Hyperoxia; Nitric oxide synthase; Osteopontin

Indexed keywords

ENDOTHELIAL NITRIC OXIDE SYNTHASE; INDUCIBLE NITRIC OXIDE SYNTHASE; MESSENGER RNA; OSTEOPONTIN;

ACUTE LUNG INJURY; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; ENZYME INHIBITION; HYPEROXIA; KNOCKOUT MOUSE; MOUSE; NONHUMAN; PROTECTION; PROTEIN EXPRESSION; PROTEIN FUNCTION; WILD TYPE;

ANIMALS; HYPEROXIA; IMMUNOHISTOCHEMISTRY; LUNG; LUNG INJURY; MICE; MICE, KNOCKOUT; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE TYPE II; NITRIC OXIDE SYNTHASE TYPE III; OSTEOPONTIN; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

EID: 77950891020     PISSN: 03666999     EISSN: None     Source Type: Journal    
DOI: 10.3760/cma.j.issn.0366-6999.2010.07.030     Document Type: Article

References (27)

1. Crapo JD, Barry BE, Foscue HA, Shelburne J. Structural and biochemical changes in rat lungs occurring during exposures to lethal and adaptive doses of oxygen. Am Rev Respir Dis 1980; 122: 123-143.
2. Adnot S, Raffestin B, Eddahibi S. NO in the lung. Respir Physiol 1995; 101: 109-120.
3. Cucchiaro G, Tatum AH, Brown MC, Camporesi EM, Daucher JW, Hakim TS. Inducible nitric oxide synthase in the lung and exhaled nitric oxide after hyperoxia. Am J Physiol 1999; 277 (3 Pt 1): L636-L644.
4. Radomski A, Sawicki G, Olson DM, Radomski MW. The role of nitric oxide and metalloproteinases in the pathogenesis of hyperoxia-induced lung injury in newborn rats. Br J Pharmacol 1998; 125: 1455-1462.
5. Denhardt DT, Giachelli CM, Rittling SR. Role of osteopontin in cellular signaling and toxicant injury. Annu Rev Pharmacol Toxicol 2001; 41: 723-749.
6. Rittling SR, Denhardt DT. Osteopontin function in pathology: lessons from osteopontin-deficient mice. Exp Nephrol 1999; 7: 103-113.
7. Sodek J, Ganss B, McKee MD. Osteopontin. Crit Rev Oral Biol Med 2000; 11: 279-303.
8. O'Regan A, Berman JS. Osteopontin: a key cytokine in cell-mediated and granulomatous inflammation. Int J Exp Pathol 2000; 81: 373-390.
9. Boucherat O, Franco-Montoya ML, Thibault C, Incitti R, Chailley-Heu B, Delacourt C, et al. Gene expression profiling in lung fibroblasts reveals new players in alveolarization. Physiol Genomics 2007; 32: 128-141.
10. O'Regan A. The role of osteopontin in lung disease. Cytokine Growth Factor Rev 2003; 14: 479-488.
11. Takahashi F, Takahashi K, Shimizu K, Cui R, Tada N, Takahashi H, et al. Osteopontin is strongly expressed by alveolar macrophages in the lungs of acute respiratory distress syndrome. Lung 2004; 182: 173-185.
12. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. Protein measurement. J Biol Chem 1951; 193: 265-275.
13. Dulon S, Candé C, Bunnett NW, Hollenberg MD, Chignard M, Pidard D. Proteinase-activated receptor-2 and human lung epithelial cells: disarming by neutrophil serine proteinases. Am J Respir Cell Mol Biol 2003; 28: 339-346.
14. Steudel W, Watanabe M, Dikranian K, Jacobson M, Jones RC. Expression of nitric oxide synthase isoforms (NOS II and NOS III) in adult rat lung in hyperoxic pulmonary hypertension. Cell Tissue Res 1999; 295: 317-329.
15. Barberà JA, Peinado VI, Santos S, Ramirez J, Roca J, Rodriguez-Roisin R. Reduced expression of endothelial nitric oxide synthase in pulmonary arteries of smokers. Am J Respir Crit Care Med 2001; 164: 709-713.
16. Godfrey K. Statistics in practice: comparing the means of several groups. N Engl J Med 1985; 313: 1450-1456.
17. Folz RJ, Crapo JD. Pulmonary oxygen toxicity. In: Tierney DF. ed. Current pulmonology, 15th ed. Chicago: Mosby Yrae-Book Inc; 1994: 13-136.
18. Pheng LH, Francoeur C, Denis M. The involvement of nitric oxide in a mouse model of adult respiratory distress syndrome. Inflammation 1995; 19: 599-612.
19. Xia HP, Huang GY, Zhu JX, Sun B. Effect of inhalation of nebulized NO donor substance on acute hypoxic lung injury in newborn piglets. Chin Med J 2008; 121: 1622-1626.
20. Hickey MJ, Sharkey KA, Sihota EG, Reinhardt PH, Macmicking JD, Nathan C, et al. Inducible nitric oxide synthase-deficient mice have enhanced leukocyte- endothelium interactions in endotoxemia. FASEB J 1997; 11: 955-964.
21. Beckman JS, Koppenol WH. Nitric oxide, superoxide, and peroxynitrite: the good, the bad, and the ugly. Am J Physiol 1996; 271 (5 Pt 1): C1424-C1437.
22. Arkovitz MS, Wispé JR, Garcia VF, Szabó C. Selective inhibition of the inducible isoform of nitric oxide synthase prevents pulmonary transvascular flux during acute endotoxemia. J Pediatr Surg 1996; 31: 1009-1015.
23. Rollo EE, Laskin DL, Denhardt DT. Osteopontin inhibits nitric oxide production and cytotoxicity by activated RAW264.7 macrophages. J Leukoc Biol 1996; 60: 397-404.
24. Singh K, Balligand JL, Fischer TA, Smith TW, Kelly RA. Glucocorticoids increase osteopontin expression in cardiac myocytes and microvascular endothelial cells. Role in regulation of inducible nitric oxide synthase. J Biol Chem 1995; 270: 28471-28478.
25. Scott JA, Weir ML, Wilson SM, Xuan JW, Chambers AF, McCormack DG. Osteopontin inhibits inducible nitric oxide synthase activity in rat vascular tissue. Am J Physiol 1998; 275 (6 Pt 2): H2258-H2265.
26. Guo H, Wai PY, Mi Z, Gao C, Zhang J, Kuo PC. Osteopontin mediates Stat1 degradation to inhibit iNOS transcription in a cecal ligation and puncture model of sepsis. Surgery 2008; 144: 182-188.
27. Matsui Y, Jia N, Okamoto H, Kon S, Onozuka H, Akino M, et al. Role of osteopontin in cardiac fibrosis and remodeling in angiotensin II-induced cardiac hypertrophy. Hypertension 2004; 43: 1195-1201.